ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SPRO Spero Therapeutics Inc

1.49
0.06 (4.20%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Spero Therapeutics Inc SPRO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.06 4.20% 1.49 08:04:29
Open Price Low Price High Price Close Price Previous Close
1.44 1.42 1.51 1.46 1.43
more quote information »

Recent News

Date Time Source Heading
07/3/202400:05GLOBESpero Therapeutics to Provide Business Update and Report..
29/2/202400:05GLOBESpero Therapeutics Announces Clearance of IND for SPR206 to..
27/2/202400:05GLOBESpero Therapeutics to Present at Cowen’s 44th Annual..
10/2/202408:05EDGAR2Form 8-K - Current report
06/2/202412:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202412:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202412:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202412:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202412:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202408:50EDGAR2Form 144 - Report of proposed sale of securities
01/2/202408:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
08/1/202422:07EDGAR2Form 8-K - Current report
06/1/202400:11EDGAR2Form 8-K - Current report
06/1/202400:05GLOBESpero Therapeutics Provides Corporate Update and 2024..
05/1/202408:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202400:13EDGAR2Form 8-K - Current report
03/1/202400:05GLOBESpero Therapeutics Announces First Patient, First Visit for..
16/11/202308:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202308:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/11/202308:50EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202308:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202308:13EDGAR2Form 8-K - Current report
14/11/202308:05GLOBESpero Therapeutics Announces Third Quarter 2023 Operating..
14/11/202308:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:45IHMARKETNEWSMonday’s Wall Street Highlights: Boeing, Novo Nordisk,..
07/11/202300:05GLOBESpero Therapeutics to Provide Business Update and Report..
02/11/202307:05GLOBESpero Therapeutics to Present at Upcoming November Investor..
01/11/202323:10EDGAR2Form 8-K - Current report
01/11/202323:05GLOBESpero Therapeutics Appoints Esther Rajavelu as Chief..
01/11/202307:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
17/10/202307:01EDGAR2Form 8-K/A - Current report: [Amend]
11/10/202308:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202308:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202323:28EDGAR2Form 8-K - Current report
30/9/202306:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
21/9/202306:05GLOBESpero Therapeutics to Present at Cantor’s Global Healthcare..
16/9/202307:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202322:05GLOBESpero Therapeutics to Present at H.C. Wainwright 25th Annual..
02/9/202306:11EDGAR2Form ARS - Annual Report to Security Holders
02/9/202306:08EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202306:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
31/8/202306:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202306:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202306:16EDGAR2Form 144 - Report of proposed sale of securities
23/8/202307:27EDGAR2Form PRE 14A - Other preliminary proxy statements
11/8/202306:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/8/202306:17EDGAR2Form 8-K - Current report
11/8/202306:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:05GLOBESpero Therapeutics Announces Second Quarter 2023 Operating..

Your Recent History

Delayed Upgrade Clock